Procyanidin composition of Chardonnay, Mauzac and Grenache blanc grapes

Dimer procyanidins, galloylated or not, and trimers were analysed in three white grape varieties: Chardonnay, Mauzac and Grenache blanc. Procyanidins were extracted from the different components of the grape cluster (seeds, stems, skins and pulps) and then quantified by HPLC. Procyanidin B1 is the major component in stems and skins while procyanidin B2 is the major component in seeds

Dimer and trimer procyanidins in Carignan and Mourvèdre grapes and red wines

Dimer procyanidins, galloylated or not, and trimers were analysed in the red grapes Carignan and Mourvedre. Procyanidins were extracted from the various parts of the grape bunch and then quantified by HPLC. In Carignan and Mourvedre grapes, procyanidin B2 was the major component in seeds, whereas procyanidin B1 was the major component in stems and skins. Trimeric procyanidins were also present in grapes in larger amounts. Various red wines were produced from Carignan and Mourvedre grapes, using different winemaking procedures: entire crushed harvest, destemmed harvest, carbonic maceration and heating of the harvest. Entire crushed harvest gave red wines with the highest levels of procyanidins. An important release of procyanidins, especially procyanidin B1 from skins and stems, when present, occurred.Procyanidines dimères et trimères des raisins et vins rouges de Carignan et MourvèdreDes procyanidines dimères galloylées et non-galloylées, et trimères sont dosées dans deux cépages rouges: Carignan et Mourvèdre. Les procyanidines sont extraites des différentes parties de la grappe puis quantifiées par CLHP en phase inverse. Dans le raisin de Carignan et de Mourvedre, la procyanidine B2 est la plus abondante dans les pepins, tandis que la procyanidine B1 est la plus abondante dans les rafles et pellicules. Les procyanidines trimères sont aussi présentes en quantités importantes. Différents vins rouges ont été élabores à partir des cépages Carignan et Mourvèdre, en utilisant plusieurs téchniques de vinification: vendange foulée; vendange éraflée, macération carbonique et le chauffage de la vendange. Les quantités les plus abondantes de procyanidines sont obtenues dans des vins issus d'une vendange entière et foulée

Optical frequency measurement of the 1S-3S two-photon transition in hydrogen

This article reports the first optical frequency measurement of the $1\mathrm{S}-3\mathrm{S}$ transition in hydrogen. The excitation of this transition occurs at a wavelength of 205 nm which is obtained with two frequency doubling stages of a titanium sapphire laser at 820 nm. Its frequency is measured with an optical frequency comb. The second-order Doppler effect is evaluated from the observation of the motional Stark effect due to a transverse magnetic field perpendicular to the atomic beam. The measured value of the $1\mathrm{S}_{1/2}(F=1)-3\mathrm{S}_{1/2}(F=1)$ frequency splitting is $2 922 742 936.729 (13) \mathrm{MHz}$ with a relative uncertainty of $4.5\times10^{-12}$. After the measurement of the $1\mathrm{S}-2\mathrm{S}$ frequency, this result is the most precise of the optical frequencies in hydrogen

Radiative Correction to the Nuclear-Size Effect and Hydrogen-Deuterium Isotopic Shift

The radiative correction to the nuclear charge radius contribution to the Lamb shift of order $\alpha(Z\alpha)^5m_r^3$ is calculated. In view of the recent high precision experimental data, this theoretical correction produces a significant contribution to the hydrogen-deuterium isotopic shift.Comment: 5 pages, REVTEX, replaced with the final version, to be published in Phys.Rev. A, two references adde

Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study

Background: Adrenomedullin (ADM) regulates vascular tone and endothelial permeability during sepsis. Levels of circulating biologically active ADM (bio-ADM) show an inverse relationship with blood pressure and a direct relationship with vasopressor requirement. In the present prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock 1 (, AdrenOSS-1) study, we assessed relationships between circulating bio-ADM during the initial intensive care unit (ICU) stay and short-term outcome in order to eventually design a biomarker-guided randomized controlled trial. Methods: AdrenOSS-1 was a prospective observational multinational study. The primary outcome was 28-day mortality. Secondary outcomes included organ failure as defined by Sequential Organ Failure Assessment (SOFA) score, organ support with focus on vasopressor/inotropic use, and need for renal replacement therapy. AdrenOSS-1 included 583 patients admitted to the ICU with sepsis or septic shock. Results: Circulating bio-ADM levels were measured upon admission and at day 2. Median bio-ADM concentration upon admission was 80.5 pg/ml [IQR 41.5-148.1 pg/ml]. Initial SOFA score was 7 [IQR 5-10], and 28-day mortality was 22%. We found marked associations between bio-ADM upon admission and 28-day mortality (unadjusted standardized HR 2.3 [CI 1.9-2.9]; adjusted HR 1.6 [CI 1.1-2.5]) and between bio-ADM levels and SOFA score (p < 0.0001). Need of vasopressor/inotrope, renal replacement therapy, and positive fluid balance were more prevalent in patients with a bio-ADM > 70 pg/ml upon admission than in those with bio-ADM ≤ 70 pg/ml. In patients with bio-ADM > 70 pg/ml upon admission, decrease in bio-ADM below 70 pg/ml at day 2 was associated with recovery of organ function at day 7 and better 28-day outcome (9.5% mortality). By contrast, persistently elevated bio-ADM at day 2 was associated with prolonged organ dysfunction and high 28-day mortality (38.1% mortality, HR 4.9, 95% CI 2.5-9.8). Conclusions: AdrenOSS-1 shows that early levels and rapid changes in bio-ADM estimate short-term outcome in sepsis and septic shock. These data are the backbone of the design of the biomarker-guided AdrenOSS-2 trial. Trial registration: ClinicalTrials.gov, NCT02393781. Registered on March 19, 2015

Les vins de l'an 2000

National audienc

Vino a zdravi

International audienc